Transforming Big Pharma (ePub)

Name: Transforming Big Pharma
Brand: Taylor & Francis
SKU: 75223339
Price: 66.99 EUR
Availability: OnlineOnly

Assessing the Strategic Alternatives (Sprache: Englisch)

Autor: John Ansell

Schreiben Sie einen Kommentar zu "Transforming Big Pharma".

Merken

Mehr zum Inhalt Autorenporträt Video

sofort als Download lieferbar

Bestellnummer: 75223339

eBook (ePub) 66.99 €

Download bestellen

Verschenken

33 DeutschlandCard Punkte sammeln

Lastschrift, Kreditkarte, Paypal, Rechnung
Kostenloser tolino webreader

Produktdetails

Produktbeschreibung
Autorenporträt
eBook Hilfe
Biblio. Angaben / Produktdetails
Download-DRM Infos

Produktinformationen zu „Transforming Big Pharma (ePub)“

Transforming Big Pharma addresses critically how strategy works in the pharmaceutical industry. John Ansell assesses the wide range of alternative strategies big pharma has been attempting in order to make up the shortfall in revenues stemming from the long-standing failure to develop sufficient new products. He shows that there is sound evidence to expect the recent upturn in the number of new products reaching the market to go on to greater heights. Whilst diversification may have some value as a stopgap, big pharma companies risk squandering their resources in directions that can only make a modest impact on their performance. Ansell argues for a reversal of recent cutbacks in R&D and licensing, and re-focussing on new product development. He shows that there is ample scope for acquiring more products from third parties. Only this strategy, Ansell contends, is likely to have the power to transform the prospects of big pharma.

Autoren-Porträt von John Ansell

John Ansell has been an independent pharmaceutical industry consultant based in the UK since 1989. He is also a Senior Partner at the CRO TranScrip Partners. He has worked with pharmaceutical companies of all shapes and sizes, and with companies serving the industry - over 150 in all. Ansell concentrates on international projects with a commercial and strategic emphasis, reflecting his previous 20 years in the pharmaceutical industry in marketing and business development. A biochemistry graduate with a Master's degree in business studies, Ansell worked first in Holland for Organon and later there for Solvay, as well as in the UK for Schering AG, Fisons and Glaxo. Since 2007 he has been an Honorary Consultant to the University of Manchester School of Pharmacy and Pharmaceutical Sciences. Ansell is the author of 50 articles and reports on pharmaceutical issues and is a frequent speaker and chair at industry conferences (see www.johnansell.com).

eBook Hilfe

Informationen und Hilfe zu eBooks hier klicken!

Bibliographische Angaben

Autor: John Ansell
2016, 284 Seiten, Englisch
Verlag: Taylor & Francis
ISBN-10: 1317007719
ISBN-13: 9781317007715
Erscheinungsdatum: 24.02.2016

Abhängig von Bildschirmgröße und eingestellter Schriftgröße kann die Seitenzahl auf Ihrem Lesegerät variieren.

eBook Informationen

Dateiformat: ePub
Größe: 1.40 MB
Mit Kopierschutz
Vorlesefunktion

Sprache:

Englisch

Kopierschutz

Dieses eBook können Sie uneingeschränkt auf allen Geräten der tolino Familie lesen. Zum Lesen auf sonstigen eReadern und am PC benötigen Sie eine Adobe ID.

Kommentar zu "Transforming Big Pharma"

Schreiben Sie einen Kommentar zu "Transforming Big Pharma".

Wie funktionieren Bewertungen?

0 Gebrauchte Artikel zu „Transforming Big Pharma“

Zustand	Preis	Porto	Zahlung	Verkäufer	Rating